
    
      Single centre, open label, balanced randomised, two-way crossover study in 12 healthy
      volunteers. The study consisted of 2 periods separated by a washout period of 7 days or more.
      On each of the study periods the volunteers received either a single 900 mg oral dose of BIA
      2-093 or a single 900 mg oral dose of Oxcarbazepine.
    
  